These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17902570)

  • 1. [Oral thyroxine treatment: towards an individually tailored dose].
    Centanni M; Franchi A; Santaguida MG; Virili C; Nardo S; Gargano L
    Recenti Prog Med; 2007 Sep; 98(9):445-51. PubMed ID: 17902570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levothyroxine in psychiatry: issues related to absorption after oral dosing.
    Andrade C
    J Clin Psychiatry; 2013 Aug; 74(8):e744-6. PubMed ID: 24021514
    [No Abstract]   [Full Text] [Related]  

  • 3. [Primary hypothyroidism: Considerations for a rational use of levothyroxine therapy].
    Bros JA; Lluís PG; Cabot GL; Pedragós AC
    Med Clin (Barc); 2011 Feb; 136(5):207-14. PubMed ID: 19646718
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of total thyroxine in dogs after administration of an oral solution of levothyroxine sodium.
    Le Traon G; Burgaud S; Horspool LJ
    J Vet Pharmacol Ther; 2008 Apr; 31(2):95-101. PubMed ID: 18307500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal Malabsorption of Thyroxine.
    Virili C; Antonelli A; Santaguida MG; Benvenga S; Centanni M
    Endocr Rev; 2019 Feb; 40(1):118-136. PubMed ID: 30476027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased thyroid-stimulating hormone levels associated with concomitant administration of levothyroxine and raloxifene.
    Garwood CL; Van Schepen KA; McDonough RP; Sullivan AL
    Pharmacotherapy; 2006 Jun; 26(6):881-5. PubMed ID: 16716142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Levothyroxine malabsortion].
    Catalina PF; Carpio D
    Med Clin (Barc); 2015 Jul; 145(1):46. PubMed ID: 25458511
    [No Abstract]   [Full Text] [Related]  

  • 9. How do you approach the problem of TSH elevation in a patient on high-dose thyroid hormone replacement?
    Morris JC
    Clin Endocrinol (Oxf); 2009 May; 70(5):671-3. PubMed ID: 19226259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypothyroidism due to pseudo-malabsorption of levothyroxine--Case 12/2009].
    Müssig K; Mörike K; Klein R; Sträter J; Georges G; Häring HU; Schnauder G
    Dtsch Med Wochenschr; 2009 Dec; 134(49):2514. PubMed ID: 19941234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malabsorption of thyroid hormone with cholestyramine administration.
    Rosenberg R
    Conn Med; 1994 Feb; 58(2):109. PubMed ID: 8004946
    [No Abstract]   [Full Text] [Related]  

  • 12. Conditions and drugs interfering with thyroxine absorption.
    Liwanpo L; Hershman JM
    Best Pract Res Clin Endocrinol Metab; 2009 Dec; 23(6):781-92. PubMed ID: 19942153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A thyroxine absorption test followed by weekly thyroxine administration: a method to assess non-adherence to treatment.
    Walker JN; Shillo P; Ibbotson V; Vincent A; Karavitaki N; Weetman AP; Wass JA; Allahabadia A
    Eur J Endocrinol; 2013 Jun; 168(6):913-7. PubMed ID: 23554450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of soy protein supplement and resultant need for increased dose of levothyroxine.
    Bell DS; Ovalle F
    Endocr Pract; 2001; 7(3):193-4. PubMed ID: 11421567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of lactose intolerance and other gastro-intestinal tract disorders on L-thyroxine absorption.
    Ruchała M; Szczepanek-Parulska E; Zybek A
    Endokrynol Pol; 2012; 63(4):318-23. PubMed ID: 22933169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levothyroxine Therapy in Gastric Malabsorptive Disorders.
    Virili C; Brusca N; Capriello S; Centanni M
    Front Endocrinol (Lausanne); 2020; 11():621616. PubMed ID: 33584549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative pH-dissolution profile study of selected commercial levothyroxine products using inductively coupled plasma mass spectrometry.
    Pabla D; Akhlaghi F; Zia H
    Eur J Pharm Biopharm; 2009 May; 72(1):105-10. PubMed ID: 18996189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of high versus low initial doses of L-thyroxine for congenital hypothyroidism on thyroid function and somatic growth.
    Jones JH; Gellén B; Paterson WF; Beaton S; Donaldson MD
    Arch Dis Child; 2008 Nov; 93(11):940-4. PubMed ID: 18456702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption kinetics of levothyroxine is not altered by proton-pump inhibitor therapy.
    Dietrich JW; Gieselbrecht K; Holl RW; Boehm BO
    Horm Metab Res; 2006 Jan; 38(1):57-9. PubMed ID: 16477543
    [No Abstract]   [Full Text] [Related]  

  • 20. Levothyroxine absorption in health and disease, and new therapeutic perspectives.
    Ianiro G; Mangiola F; Di Rienzo TA; Bibbò S; Franceschi F; Greco AV; Gasbarrini A
    Eur Rev Med Pharmacol Sci; 2014; 18(4):451-6. PubMed ID: 24610609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.